^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Anruixi (zuberitamab)

    i
    Other names: HS006, HS 006, RHCACD20MA, HS-006, RHCACD 20MA, RHCAD-20-MA
    Associations
    News
    Trials
    Company:
    Zhejiang Hisun
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations
    News
    Trials